annual net income:
$7.04B+$1.08B(+18.14%)Summary
- As of today (April 13, 2025), AZN annual net profit is $7.04 billion, with the most recent change of +$1.08 billion (+18.14%) on December 31, 2024.
- During the last 3 years, AZN annual net income has risen by +$6.92 billion (+6181.25%).
- AZN annual net income is now -29.06% below its all-time high of $9.92 billion, reached on December 31, 2011.
Performance
AZN Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$1.50B+$71.00M(+4.97%)Summary
- As of today (April 13, 2025), AZN quarterly net profit is $1.50 billion, with the most recent change of +$71.00 million (+4.97%) on December 31, 2024.
- Over the past year, AZN quarterly net income has stayed the same.
- AZN quarterly net income is now -56.86% below its all-time high of $3.48 billion, reached on September 30, 2011.
Performance
AZN quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
$7.04B+$540.00M(+8.31%)Summary
- As of today (April 13, 2025), AZN TTM net profit is $7.04 billion, with the most recent change of +$540.00 million (+8.31%) on December 31, 2024.
- Over the past year, AZN TTM net income has stayed the same.
- AZN TTM net income is now -30.47% below its all-time high of $10.12 billion, reached on September 30, 2011.
Performance
AZN TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
AZN Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.1% | 0.0% | 0.0% |
| 3 y3 years | +6181.3% | +316.7% | +661.5% |
| 5 y5 years | +427.0% | +316.7% | +661.5% |
AZN Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +6181.3% | -31.2% | +316.7% | at high | +661.5% |
| 5 y | 5-year | at high | +6181.3% | -31.2% | +190.8% | at high | +661.5% |
| alltime | all time | -29.1% | +6181.3% | -56.9% | +190.8% | -30.5% | +661.5% |
AstraZeneca Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $7.04B(+18.1%) | $1.50B(+5.0%) | $7.04B(+8.3%) |
| Sep 2024 | - | $1.43B(-25.8%) | $6.50B(+0.9%) |
| Jun 2024 | - | $1.93B(-11.6%) | $6.44B(+1.7%) |
| Mar 2024 | - | $2.18B(+127.0%) | $6.33B(+6.3%) |
| Dec 2023 | $5.96B(+81.1%) | $960.00M(-30.1%) | $5.96B(+1.0%) |
| Sep 2023 | - | $1.37B(-24.4%) | $5.90B(-4.3%) |
| Jun 2023 | - | $1.82B(+0.8%) | $6.16B(+31.0%) |
| Mar 2023 | - | $1.80B(+100.1%) | $4.70B(+43.1%) |
| Dec 2022 | $3.29B(+2835.7%) | $901.00M(-45.1%) | $3.29B(+61.2%) |
| Sep 2022 | - | $1.64B(+355.6%) | $2.04B(-262.7%) |
| Jun 2022 | - | $360.00M(-6.7%) | -$1.25B(+17.9%) |
| Mar 2022 | - | $386.00M(-211.2%) | -$1.06B(-1049.1%) |
| Dec 2021 | $112.00M(-96.5%) | -$347.00M(-79.0%) | $112.00M(-92.4%) |
| Sep 2021 | - | -$1.65B(-400.4%) | $1.47B(-61.0%) |
| Jun 2021 | - | $550.00M(-64.8%) | $3.77B(-5.2%) |
| Mar 2021 | - | $1.56B(+54.2%) | $3.98B(+24.4%) |
| Dec 2020 | $3.20B(+139.4%) | $1.01B(+56.2%) | $3.20B(+28.0%) |
| Sep 2020 | - | $648.00M(-14.3%) | $2.50B(+16.2%) |
| Jun 2020 | - | $756.00M(-3.1%) | $2.15B(+41.1%) |
| Mar 2020 | - | $780.00M(+149.2%) | $1.52B(+14.0%) |
| Dec 2019 | $1.33B(-38.1%) | $313.00M(+4.7%) | $1.33B(-35.1%) |
| Sep 2019 | - | $299.00M(+130.0%) | $2.06B(-6.0%) |
| Jun 2019 | - | $130.00M(-78.1%) | $2.19B(-9.1%) |
| Mar 2019 | - | $593.00M(-42.6%) | $2.41B(+11.7%) |
| Dec 2018 | $2.15B(-28.2%) | $1.03B(+139.9%) | $2.15B(-11.0%) |
| Sep 2018 | - | $431.00M(+23.1%) | $2.42B(-9.5%) |
| Jun 2018 | - | $350.00M(+2.9%) | $2.68B(-4.5%) |
| Mar 2018 | - | $340.00M(-73.9%) | $2.80B(-6.6%) |
| Dec 2017 | $3.00B(-14.2%) | $1.30B(+89.7%) | $3.00B(-15.3%) |
| Sep 2017 | - | $686.00M(+43.8%) | $3.54B(-8.5%) |
| Jun 2017 | - | $477.00M(-11.2%) | $3.87B(+14.2%) |
| Mar 2017 | - | $537.00M(-70.8%) | $3.39B(-3.1%) |
| Dec 2016 | $3.50B(+23.9%) | $1.84B(+81.7%) | $3.50B(+41.9%) |
| Sep 2016 | - | $1.01B(<-9900.0%) | $2.46B(+11.0%) |
| Jun 2016 | - | -$3.00M(-100.5%) | $2.22B(-24.0%) |
| Mar 2016 | - | $646.00M(-20.0%) | $2.92B(+3.4%) |
| Dec 2015 | $2.83B(+129.1%) | $808.00M(+4.9%) | $2.83B(+66.6%) |
| Sep 2015 | - | $770.00M(+10.5%) | $1.70B(+43.7%) |
| Jun 2015 | - | $697.00M(+26.7%) | $1.18B(-7.7%) |
| Mar 2015 | - | $550.00M(-271.3%) | $1.28B(+3.7%) |
| Dec 2014 | $1.23B(-51.8%) | -$321.00M(-226.4%) | $1.23B(+19.7%) |
| Sep 2014 | - | $254.00M(-68.1%) | $1.03B(-49.1%) |
| Jun 2014 | - | $796.00M(+57.9%) | $2.02B(-1.3%) |
| Mar 2014 | - | $504.00M(-196.2%) | $2.05B(-19.8%) |
| Dec 2013 | $2.56B(-59.0%) | -$524.00M(-142.1%) | $2.56B(-44.3%) |
| Sep 2013 | - | $1.25B(+51.4%) | $4.59B(-5.5%) |
| Jun 2013 | - | $823.00M(-18.6%) | $4.85B(-13.8%) |
| Mar 2013 | - | $1.01B(-32.9%) | $5.63B(-9.8%) |
| Dec 2012 | $6.24B(-37.1%) | $1.51B(-0.3%) | $6.24B(+1.4%) |
| Sep 2012 | - | $1.51B(-5.4%) | $6.15B(-24.2%) |
| Jun 2012 | - | $1.60B(-1.7%) | $8.12B(-6.0%) |
| Mar 2012 | - | $1.63B(+14.4%) | $8.63B(-12.9%) |
| Dec 2011 | $9.92B(+23.1%) | $1.42B(-59.2%) | $9.92B(-2.0%) |
| Sep 2011 | - | $3.48B(+64.6%) | $10.12B(+23.6%) |
| Jun 2011 | - | $2.11B(-27.3%) | $8.19B(+0.1%) |
| Mar 2011 | - | $2.91B(+79.3%) | $8.18B(+1.6%) |
| Dec 2010 | $8.05B(+7.1%) | $1.62B(+4.7%) | $8.05B(+0.9%) |
| Sep 2010 | - | $1.55B(-26.5%) | $7.99B(-6.6%) |
| Jun 2010 | - | $2.11B(-24.1%) | $8.55B(+4.9%) |
| Mar 2010 | - | $2.78B(+78.8%) | $8.15B(+8.4%) |
| Dec 2009 | $7.52B(+23.3%) | $1.55B(-26.6%) | $7.52B(+4.2%) |
| Sep 2009 | - | $2.12B(+23.9%) | $7.22B(+5.6%) |
| Jun 2009 | - | $1.71B(-20.5%) | $6.83B(+1.3%) |
| Mar 2009 | - | $2.15B(+72.0%) | $6.74B(+10.5%) |
| Dec 2008 | $6.10B | $1.25B(-27.9%) | $6.10B(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2008 | - | $1.73B(+6.8%) | $6.12B(+6.8%) |
| Jun 2008 | - | $1.62B(+7.8%) | $5.73B(+3.5%) |
| Mar 2008 | - | $1.50B(+18.7%) | $5.54B(-1.0%) |
| Dec 2007 | $5.59B(-7.4%) | $1.27B(-5.7%) | $5.59B(-2.9%) |
| Sep 2007 | - | $1.34B(-5.8%) | $5.76B(-4.1%) |
| Jun 2007 | - | $1.43B(-8.6%) | $6.00B(-2.8%) |
| Mar 2007 | - | $1.56B(+8.9%) | $6.18B(+2.3%) |
| Dec 2006 | $6.04B(+28.4%) | $1.43B(-9.8%) | $6.04B(+3.6%) |
| Sep 2006 | - | $1.59B(-0.8%) | $5.83B(+6.7%) |
| Jun 2006 | - | $1.60B(+12.4%) | $5.47B(+7.5%) |
| Mar 2006 | - | $1.42B(+16.3%) | $5.09B(+8.2%) |
| Dec 2005 | $4.71B(+28.4%) | $1.22B(+0.1%) | $4.71B(+6.8%) |
| Sep 2005 | - | $1.22B(+0.3%) | $4.41B(+2.1%) |
| Jun 2005 | - | $1.22B(+17.2%) | $4.32B(+10.4%) |
| Mar 2005 | - | $1.04B(+12.7%) | $3.91B(+6.6%) |
| Dec 2004 | $3.66B(+21.2%) | $923.00M(-18.5%) | $3.66B(+9.0%) |
| Sep 2004 | - | $1.13B(+39.7%) | $3.36B(+11.0%) |
| Jun 2004 | - | $811.00M(+1.8%) | $3.03B(+4.9%) |
| Mar 2004 | - | $797.00M(+28.3%) | $2.89B(-4.5%) |
| Dec 2003 | $3.02B(+6.6%) | $621.00M(-22.2%) | $3.02B(+6.6%) |
| Sep 2003 | - | $798.55M(+19.4%) | $2.83B(+4.8%) |
| Jun 2003 | - | $668.92M(-28.3%) | $2.71B(-3.8%) |
| Mar 2003 | - | $933.54M(+115.5%) | $2.81B(-0.9%) |
| Dec 2002 | $2.84B(-4.4%) | $433.29M(-35.3%) | $2.84B(-11.1%) |
| Sep 2002 | - | $669.71M(-13.6%) | $3.19B(-1.3%) |
| Jun 2002 | - | $775.00M(-19.1%) | $3.23B(+2.8%) |
| Mar 2002 | - | $958.00M(+21.7%) | $3.14B(+6.0%) |
| Dec 2001 | $2.97B(+16.8%) | $787.00M(+10.7%) | $2.96B(+8.7%) |
| Sep 2001 | - | $711.00M(+3.6%) | $2.73B(+2.2%) |
| Jun 2001 | - | $686.00M(-12.1%) | $2.67B(+0.3%) |
| Mar 2001 | - | $780.46M(+42.1%) | $2.66B(+4.7%) |
| Dec 2000 | $2.54B(+122.3%) | $549.27M(-15.6%) | $2.54B(+39.7%) |
| Sep 2000 | - | $651.18M(-4.1%) | $1.82B(+10.1%) |
| Jun 2000 | - | $679.03M(+2.7%) | $1.65B(+18.9%) |
| Mar 2000 | - | $661.15M(-482.2%) | $1.39B(+21.4%) |
| Dec 1999 | $1.14B(-56.2%) | -$173.00M(-135.7%) | $1.14B(-61.2%) |
| Sep 1999 | - | $484.00M(+16.3%) | $2.95B(+9.3%) |
| Jun 1999 | - | $416.00M(0.0%) | $2.70B(-10.1%) |
| Mar 1999 | - | $416.00M(-74.5%) | $3.00B(+1.7%) |
| Dec 1998 | $2.61B(+116.4%) | $1.63B(+598.7%) | $2.95B(+79.8%) |
| Sep 1998 | - | $233.40M(-67.6%) | $1.64B(-3.6%) |
| Jun 1998 | - | $720.00M(+96.7%) | $1.70B(+25.6%) |
| Mar 1998 | - | $366.00M(+13.8%) | $1.36B(-0.5%) |
| Dec 1997 | $1.21B(+9.6%) | $321.57M(+9.0%) | $1.36B(-18.5%) |
| Sep 1997 | - | $295.10M(-20.8%) | $1.67B(+3.7%) |
| Jun 1997 | - | $372.50M(0.0%) | $1.61B(+3.7%) |
| Mar 1997 | - | $372.50M(-40.9%) | $1.55B(+3.8%) |
| Dec 1996 | $1.10B(+112.1%) | $630.04M(+167.4%) | $1.50B(+51.6%) |
| Sep 1996 | - | $235.60M(-25.2%) | $986.59M(+11.6%) |
| Jun 1996 | - | $315.00M(0.0%) | $883.69M(+5.4%) |
| Mar 1996 | - | $315.00M(+160.3%) | $838.19M(+5.8%) |
| Dec 1995 | $519.19M(-25.0%) | $120.99M(-8.8%) | $792.59M(-20.6%) |
| Sep 1995 | - | $132.70M(-50.8%) | $998.69M(-3.9%) |
| Jun 1995 | - | $269.50M(+0.0%) | $1.04B(-7.0%) |
| Mar 1995 | - | $269.40M(-17.6%) | $1.12B(+7.3%) |
| Dec 1994 | $692.59M(+8.6%) | $327.09M(+88.7%) | $1.04B(+24.4%) |
| Sep 1994 | - | $173.30M(-50.2%) | $837.64M(+4.7%) |
| Jun 1994 | - | $348.10M(+79.7%) | $800.34M(+24.7%) |
| Mar 1994 | - | $193.70M(+58.1%) | $641.74M(+0.7%) |
| Dec 1993 | $637.54M(+425.4%) | $122.54M(-9.9%) | $637.54M(+23.8%) |
| Sep 1993 | - | $136.00M(-28.2%) | $515.00M(+35.9%) |
| Jun 1993 | - | $189.50M(0.0%) | $379.00M(+100.0%) |
| Mar 1993 | - | $189.50M | $189.50M |
| Dec 1992 | $121.34M(-81.2%) | - | - |
| Dec 1991 | $645.56M(+50.8%) | - | - |
| Dec 1990 | $428.22M | - | - |
FAQ
- What is AstraZeneca annual net profit?
- What is the all time high annual net income for AstraZeneca?
- What is AstraZeneca annual net income year-on-year change?
- What is AstraZeneca quarterly net profit?
- What is the all time high quarterly net income for AstraZeneca?
- What is AstraZeneca quarterly net income year-on-year change?
- What is AstraZeneca TTM net profit?
- What is the all time high TTM net income for AstraZeneca?
- What is AstraZeneca TTM net income year-on-year change?
What is AstraZeneca annual net profit?
The current annual net income of AZN is $7.04B
What is the all time high annual net income for AstraZeneca?
AstraZeneca all-time high annual net profit is $9.92B
What is AstraZeneca annual net income year-on-year change?
Over the past year, AZN annual net profit has changed by +$1.08B (+18.14%)
What is AstraZeneca quarterly net profit?
The current quarterly net income of AZN is $1.50B
What is the all time high quarterly net income for AstraZeneca?
AstraZeneca all-time high quarterly net profit is $3.48B
What is AstraZeneca quarterly net income year-on-year change?
Over the past year, AZN quarterly net profit has changed by $0.00 (0.00%)
What is AstraZeneca TTM net profit?
The current TTM net income of AZN is $7.04B
What is the all time high TTM net income for AstraZeneca?
AstraZeneca all-time high TTM net profit is $10.12B
What is AstraZeneca TTM net income year-on-year change?
Over the past year, AZN TTM net profit has changed by $0.00 (0.00%)